MDGL
Madrigal Pharmaceuticals, Inc.Company with tickers: MDGL
CIK
1157601
CUSIP
558868105
Shares Outstanding
23,055,659
13F Activity (30d)
196 filings
195 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-02-26 | — | |
| 10-K | 2020-02-26 | 2019-12-31 | |
| 10-Q | 2020-05-07 | 2020-03-31 | |
| 8-K | 2020-05-07 | — | |
| 8-K | 2020-06-18 | 2020-06-17 | |
| 8-K | 2020-08-06 | — | |
| 10-Q | 2020-08-06 | 2020-06-30 | |
| 8-K | 2020-11-05 | — | |
| 10-Q | 2020-11-05 | 2020-09-30 | |
| 8-K | 2021-02-25 | — | |
| 10-K | 2021-02-25 | 2020-12-31 | |
| 10-Q | 2021-05-06 | 2021-03-31 | |
| 8-K | 2021-05-06 | — | |
| 8-K | 2021-05-18 | 2021-05-17 | |
| 8-K | 2021-06-01 | — | |
| 8-K | 2021-06-21 | 2021-06-17 | |
| 8-K | 2021-08-05 | — | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-11-04 | — | |
| 10-Q | 2021-11-04 | 2021-09-30 | |
| 8-K | 2022-02-24 | — | |
| 10-K | 2022-02-24 | 2021-12-31 | |
| 10-Q | 2022-05-09 | 2022-03-31 | |
| 8-K | 2022-05-09 | — | |
| 8-K | 2022-06-17 | 2022-06-15 | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-08-04 | — | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-11-03 | — | |
| 8-K | 2022-12-19 | — | |
| 8-K | 2022-12-23 | 2022-12-19 | |
| 8-K | 2023-01-10 | 2023-01-06 | |
| 8-K | 2023-02-09 | 2023-02-03 | |
| 8-K | 2023-02-23 | — | |
| 10-K | 2023-02-23 | 2022-12-31 | |
| 10-K/A | 2023-03-03 | 2022-12-31 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| 8-K | 2023-06-20 | 2023-06-15 | |
| 8-K | 2023-06-30 | — | |
| 8-K | 2023-07-17 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-08 | — | |
| 8-K | 2023-09-13 | 2023-09-12 | |
| 8-K | 2023-09-13 | 2023-09-07 | |
| 8-K | 2023-09-14 | 2023-09-08 | |
| 8-K | 2023-09-25 | 2023-09-20 | |
| 8-K | 2023-10-02 | 2023-09-28 | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 |
Showing 1–50 of 85 filings